TheEdgeResearch
Home / Stocks / ATRI

Atrion Corporation (ATRI)

NASDAQ Healthcare Medical - Instruments & Supplies
$459.92 ▲ +0.06%
Market Cap
$809.4M
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
0.69
52-Wk Range
274.98-503.24
CEO
David A. Battat
Country
US
Currency
USD

Atrion Corporation operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Allen, TX, US. The stock last traded at $459.92, up 0.06% on the session, giving a market capitalisation of $809.4M. On trailing twelve-month figures it carries a trailing P/E of 41.74, a net margin of 11.5%. Its beta of 0.69 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
41.74
Price / Sales
4.78
Price / Book
3.33
EV / EBITDA
21.40
Gross margin
36.8%
Operating margin
13.3%
Net margin
11.5%
Return on equity
Debt / equity
0.00
Current ratio
9.09
Dividend yield
1.9%
Payout ratio
78.9%
Company profile
Exchange
NASDAQ Global Select
Employees
712
IPO date
1980-03-18
Headquarters
Allen, TX, US
About Atrion Corporation

Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.

Comparable companies

Atrion Corporation is most often compared with the following Healthcare names:

AORTASLNCDMOCMRXCSIIHARPICPTICVXIKNAPETQ
More research on ATRI
ATRI technical analysis ATRI TheEdge Score Compare against peers
Open full interactive analysis & DCF →